A critical role for fas ligand in the active suppression of systemic immune responses by ultraviolet radiation

Journal of Experimental Medicine

Volumn 189, Issue 8, 1999, Pages 1285-1293

  Hill, Laurie L ^a   Shreedhar, Vijay K ^a,b   Kripke, Margaret L ^a   Owen Schaub, Laurie B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CD95; Fas ligand; Immunosuppression; T suppressor cells; Ultraviolet radiation

Indexed keywords

FAS LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA DAMAGE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; RADIATION HAZARD; SKIN CANCER; ULTRAVIOLET RADIATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD95; CANDIDA ALBICANS; DERMATITIS, CONTACT; DNA DAMAGE; FAS LIGAND PROTEIN; FLUORESCEIN-5-ISOTHIOCYANATE; HYPERSENSITIVITY, DELAYED; IMMUNITY; ISOANTIGENS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; SPLEEN; T-LYMPHOCYTES; ULTRAVIOLET RAYS;

EID: 0033583526     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.8.1285     Document Type: Article

References (67)

1. Whittaker, S. 1996. Sun and skin cancer. Br. J. Hosp. Med. 56:515-518.
2. Fisher, M.S., and M.L. Kripke. 1977. Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis. Prof. Natl. Acad. Sci. USA. 74:1688-1692.
3. Gutierrez-Steil, C., T. Wrone-Smith, X. Sun, J.G. Krueger, T. Coven, and B. Nickoloff. 1998. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J. Clin. Investig, 101: 33-39.
4. Orlin, J.B., and M.H. Ellis. 1997. Transfusion-associated graft-versus-host disease. Curr. Opin. Hematol. 4:442-448.
5. Rook, A.M., S.L. Gottlieb, J.T. Wolfe, B.R. Vowels, S.S. Sood, Z. Niu, S.R. Lessin, and F.E. Fox. 1997. Pathogenesis of cutaneous T cell lymphoma: implications for the use of recombinant cytokines and photopheresis. Clin. Exp. Immunol. 107:16-20.
6. Kripke, M.L. 1984. Immunological unresponsiveness induced by ultraviolet radiation. Immunol. Rev. 80:87-102.
7. Yoshikawa, T., and J.W. Streilein. 1990. Genetic basis of the effects of ultraviolet-B on cutaneous immunity. Evidence that polymorphism at the TNFα and Lps loci governs susceptibility. Immunogenetics. 32:398-405.
8. Streilein, J.W., and P.R. Bergstresser. 1988. Genetic basis of ultraviolet-B on contact hypersensitivity. Immunogenetics. 27: 252-258.
9. Denkins, Y., I.J. Fidler, and M.L. Kripke. 1989. Exposure of mice to UV-B radiation suppresses delayed hypersensitivity to Candida albicans. Photochem. Photobiol. 49:615-619.
10. Kripke, M.L. 1994. Ultraviolet radiation and immunology: something new under the sun - Presidential Address. Cancer Res. 54:6102-6105.
11. Elmets, C.A., P.R. Bergstresser, R.E. Tigelaar, P.J. Wood, and J. W. Streilein. 1983. Analysis of the mechanism of unresponsiveness produced by haptens painted on the skin exposed to low dose ultraviolet radiation. J. Exp. Med. 158: 781-794.
12. Noonan, F.P., E.C. DeFabo, and M.L. Kripke. 1981. Suppression of contact hypersensitivity by UV radiation and its relation to UV-induced suppression of tumor immunity. Photochem. Photobiol. 34:683-689.
13. Fisher, M.S., and M.L. Kripke. 1982. Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice. Science. 216:1133-1134.
14. Ullrich, S.E., and M.L. Kripke. 1984. Mechanisms in the suppression of tumor rejection produced in mice by repeated UV irradiation. J. Immunol 133:2786-2790.
15. Ullrich, S.E., and M.J. Magee. 1988. Specific suppression of allograft rejection after treatment of recipient mice with UV radiation and allogeneic spleen cells. Transplantation. 46: 115-119.
16. Kripke, M.L., W.L. Morison, and J.A. Parrish. 1983. Systemic suppression of contact hypersensitivity in mice by psoralen plus UVA (PUVA). J. Invest. Dermatol. 81:87-92.
17. Ullrich, S.E. 1985. Suppression of lymphoproliferation by hapten-specific suppressor T lymphocytes from mice exposed to ultraviolet radiation. Immunology. 54:343-348.
18. Ullrich, S.E. 1987. The effect of ultraviolet radiation-induced suppressor cells on T-cell activity. Immunology. 60:353-360.
19. Rivas, J.M., and S.E. Ullrich. 1994. The role of IL-4, IL-10, and TNF-α in the immune suppression induced by ultraviolet radiation. J. Leuk. biol. 56:769-775.
20. Rivas, J., and S.E. Ullrich. 1992. Systemic suppression of DTH by supernatants from UV-irradiated keratinocytes: an essential role for interleukin 10. J. Immunol. 149:3865-3871.
21. Araneo, B., T. Dowell, H.B. Moon, and R.A. Daynes. 1989. Regulation of murine lymphocyte production in vivo. UV radiation depresses IL-2 and enhances IL-4 production by T cells through an IL-1 dependent mechanism. J. Immunol. 143:1737-1742.
22. + cells of the T helper 2 subset. J. Immunol. 145:2087-2091.
23. Simon, J.C., R.E. Tigelaar, P.R. Bergstresser, D. Edelbaum, and P.D. Cruz. 1991. Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells. J. Immnnol. 146:485-491.
24. Schmitt, D.A., L. Owen-Schaub, and S.E. Ullrich. 1995. Effect of IL-12 on immune suppression and suppressor cell induction by ultraviolet radiation. J. Immunol. 154:5114-5120.
25. Kripke, M.L., P.A. Cox, P.G. Alas, and D.B. Yarosh. 1992. Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc. Natl. Acad. Sci. USA. 89:7516-7520.
26. Kripke, M.L., P.A. Cox, C.B. Bucana, A.A. Vink, L. Alas, and D.B. Yarosh. 1996. Role of DNA damage in local suppression of contact hypersensitivity in mice by UV radiation. Exp. Dermatol. 5:173-180.
27. Vink, A.A., F.M. Strickland, C. Bucana, P.A. Cox, L. Roza, D.B. Yarosh, and M.L. Kripke. 1996. Localization of DNA damage and its role in altered antigen presenting cell function in ultraviolet-irradiated mice. J. Exp. Med. 183:1491-1500.
28. Nishigori, C., D. Yarosh, A. O'Connor, V.K. Shreedhar, S.E. Ullrich, P. Cox, and M.L. Kripke. 1998. HindIII liposomes suppress delayed-type hypersensitivity responses in vivo and induce epidermal IL-10 in vitro. J. Immunol. 161: 2684-2691.
29. O'Connor, A., C. Nishigori, D. Yarosh, L. Alas, J. Kibitel, L. Burley, P. Cox, C. Bucanc, S. Ullrich, and M. Kripke. 1996. DNA double strand breaks in epidermal cells cause immune suppression in vivo and cytokine production in vitro. J. Immunol. 157:271-278.
30. Nagata, S. 1997. Apoptosis by death factor. Cell. 88:355-365.
31. Owen-Schaub, L.B., S. Yonehara, W.L. Crump, and E.A. Grimm. 1992. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140:197-205.
32. Miyawaki, T., T. Uehara, R. Nibu, T. Tsuji, A. Yachie, S. Yonehara, and N. Taniguchi. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149:3753-3758.
33. Singer, G.G., and A.K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity. 1:365-371.
34. Griffith, T.S., T. Brunner, S.M. Fletcher, D.R. Green, and T.A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1189-1192.
35. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R.C. Duke. 1995. A role for CD95 ligand in preventing graft rejection. Nature. 377:630-632.
36. Müller, M., S. Strand, H. Hug, E.-M. Heinemann, H. Walczak, W.J. Hoffmann, W. Stremmel, P.H. Krammer, and P.R. Galle. 1997. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Investig. 99:403-413.
37. Milik, A.M., V.A. Buechner-Maxwell, J. Sonstein, S. Kim, G.D. Seitzman, T.F. Beals, and J.L. Curtis. 1997. Lung lymphocyte elimination by apoptosis in the murine response to intratracheal particulate antigen. J. Clin. Investig. 99:1082-1091.
38. Ju, S.T., D.J. Panka, H. Cul, R. Ettinger, M. El-Khatib, D.H. Sherr, B.Z. Stanger, and A. Marshak-Rothstein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 373:444-448.
39. Alderson, M.R., T.W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K.A. Schooley, R.G. Goodwin, C.A. Smith, F. Ramsdell, and D.H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
40. Brunner, T., R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverri, S.J. Martin, W.R. Force, D.H. Lynch, C.F. Ware, and D.R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature. 373:441-444.
41. Dhein, J., H. Walczak, C. Bäumler, K.M. Debatin, and P.H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 373:438-441.
42. Zhang, X., T. Brunner, L. Carter, R.W. Dutton, P. Rogers, L. Bradley, T. Sato, J.C. Reed, D. Green, and S.L. Swain. 1997. Unequal death in T helper (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J. Exp. Med. 185:1837-1849.
43. Saijo, S., C.D. Bucana, K.M. Rameriz, P.A. Cox, M.L. Kripke, and F.M. Strickland. 1995. Deficient antigen presentation and Ts induction are separate effects of ultraviolet irradiation. Cell. Immunol. 164:189-202.
44. Wu, J., T. Zhou, J. He, and J.D. Mountz. 1993. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178:461-468.
45. Watanabe-Fukunaga, R., C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 356:314-317.
46. Chu, J.-L., J. Drappa, A. Parnassa, and K.B. Elkon. 1993. The defect in Fas mRNA expression in MRL/Ipr mice is associated with insertion of the retrotransposon, ETn. J. Exp. Med. 178:723-730.
47. Adachi, M., R. Watanabe-Fukunaga, and S. Nagata. 1993. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA. 90:1756-1760.
48. Mariani, S.M., B. Matiba, E.A. Armandola, and P.H. Krammer. 1994. The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur. J. Immunol. 24:3119-3123.
49. Takahashi, T., M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 76:969-976.
50. Hahne, M., M.C. Peitsch, M. Irmler, M. Schröter, B. Lowin, M. Rousseau, C. Bron, T. Renno, L. French, and J. Tschopp. 1995. Characterization of the non-functional Fas ligand of gld mice. Int. Immunol. 7:1381-1386.
51. Ramsdell, F., M.S. Seaman, R.E. Miller, T.W. Tough, M.R. Alderson, and D.H. Lynch. 1994. gld/gld mice are unable to express a functional ligand for Fas. Eur. J. Immunol. 24:928-933.
52. Booker, J.K., E.A. Reap, and P.L. Cohen. 1998. Expression and function of Fas on cells damaged by gamma irradiation in B6 and B6/lpr mice. J. Immunol. 161:4536-4541.
53. Watanabe, D., T. Suda, H. Hashimoto, and S. Nagata. 1995. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO (Eur. Mol. Biol. Organ.) J. 14:12-18.
54. Süss, G., and K. Shortman. 1996. A subclass of dendritic cells kills CD4 T cells via Fas/Fas ligand-induced apoptosis. J. Exp. Med. 183:1789-1796.
55. Suzuki, I., and P.J. Fink. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187:123-128.
56. Leithäuser, F., J. Dhein, G. Mechtersheimer, K. Koretz, S. Brüderlein, C. Henne, A. Schmidt, K.-M. Debatin, P.H. Krammer, and P. Möller. 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69:415-429.
57. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1169-1178.
58. Reap, E.A., K. Roof, K. Maynor, M. Borrero, J. Booker, and P.L. Cohen. 1997. Radiation and stress-induced apoptosis: a role for Fas/Fas ligand interactions. Proc. Natl. Acad. Sci. USA. 94:5750-5755.
59. Griffith, T.S., X. Yu, J.M. Herndon, D.R. Green, and T.A. Ferguson. 1996. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity. 5:7-16.
60. Yoshikawa, T., and J.W. Streilein. 1990. Tumor necrosis factor-alpha and ultraviolet light have similar effects on contact hypersensitivity in mice. Reg. Immunol. 3:139-144.
61. Kasibhatla, S., T. Brunner, L. Genestier, F. Echeverri, A. Mahboubi, and D.R. Green. 1998. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol. Cell. 1:543-551.
62. Alderson, M.R., R.J. Armitage, E. Marakovsky, T.W. Tough, E. Roux, K. Schooley, F. Ramsdell, and D.H. Lynch. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178:2231-2235.
63. Okamoto, H., and M.L. Kripke. 1987. Effector and suppressor circuits of the immune response are activated in vivo by different mechanisms. Proc. Natl. Acad. Sci. USA. 84:3841-3845.
64. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:737-742.
65. Hart, P.H., M.A. Grimbaldeston, G.J. Swift, A. Jaksie, F.P. Noonan, and J.J. Finlay-Jones. 1998. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J. Exp. Med. 187:2045-2053.
66. Schwartz, A., S. Grabbe, K. Grosse-Heitmeyer, B. Roters, H. Reimann, T.A. Luger, G. Trinchieri, and T. Schwartz. 1998. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system. J. Immunol. 160:4262-4270.
67. Niizeki, H., and J.W. Streilein. 1997. Hapten-specific tolerance induced by acute, low-dose ultraviolet B radiation of skin is mediated via interleukin-10. J. Invest. Dermatol. 109: 25-30.